Company Search:
Advanced Search
Sponsored Links
Aytu Bioscience Inc Company Snapshot
Aytu Bioscience Inc operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Aytu Bioscience Inc with three other companies in this sector in the United States: Starpharma Holdings Limited (2019 sales of $1.94 million of which 100% was Dendritic), Pharmaxis Ltd ($8.97 million of which 48% was New Drug Development), and Immutep Ltd ($4.31 million of which 93% was Cancer Immunotherapy).

Sales Analysis. During the year ended June of 2019, sales at Aytu Bioscience Inc were $7.32 million. This is an increase of 100.0% versus 2018, when the company's sales were $3.66 million. This was the fifth consecutive year of sales increases at Aytu Bioscience Inc (and since 2014, sales have increased a total of 731,936%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Aytu Bioscience Inc
  Stock Performance Chart for Aytu Bioscience Inc
  Stock Data: Recent Stock Performance:
  Current Price (12/6/2019): .74
(Figures in U.S. Dollars)
1 Week -11.9%   13 Weeks -25.9%  
4 Weeks -44.0%   52 Weeks -23.9%  
Aytu Bioscience Inc Key Data:
  Ticker: AYTU Country: United States
  Exchanges: OTC Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2019 Sales 7,320,357
(Year Ending Jan 2020).
Employees: 53
  Currency: U.S. Dollars Market Cap: 13,288,028
  Fiscal Yr Ends: June Shares Outstanding: 17,981,094
  Share Type: Common Closely Held Shares: 1,956,693
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.